Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Radiopharmacological characterization of ⁶⁴Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma.

Gao F, Sihver W, Jurischka C, Bergmann R, Haase-Kohn C, Mosch B, Steinbach J, Carta D, Bolzati C, Calderan A, Pietzsch J, Pietzsch HJ.

Amino Acids. 2016 Mar;48(3):833-847. doi: 10.1007/s00726-015-2131-x. Epub 2015 Dec 7.

PMID:
26643502
2.

Effects of Trehalose on Thermodynamic Properties of Alpha-synuclein Revealed through Synchrotron Radiation Circular Dichroism.

Ruzza P, Hussain R, Biondi B, Calderan A, Tessari I, Bubacco L, Siligardi G.

Biomolecules. 2015 May 4;5(2):724-34. doi: 10.3390/biom5020724.

3.

Peptides as modulators of α-synuclein aggregation.

Ruzza P, Gazziero M, Marchi MD, Massalongo G, Marchiani A, Autiero I, Tessari I, Bubacco L, Calderan A.

Protein Pept Lett. 2015;22(4):354-61.

PMID:
25666040
4.

Glutathione Transferase (GST)-Activated Prodrugs.

Ruzza P, Calderan A.

Pharmaceutics. 2013 Apr 2;5(2):220-31. doi: 10.3390/pharmaceutics5020220.

5.

Peptide-receptor ligands and multivalent approach.

Ruzza P, Marchiani A, Antolini N, Calderan A.

Anticancer Agents Med Chem. 2012 Jun;12(5):416-27. Review.

PMID:
22292761
6.

Radiolabeled peptide-receptor ligands in tumor imaging.

Ruzza P, Calderan A.

Expert Opin Med Diagn. 2011 Sep;5(5):411-24. doi: 10.1517/17530059.2011.592829. Epub 2011 Jun 15.

PMID:
23484627
7.

Antamanide, a derivative of Amanita phalloides, is a novel inhibitor of the mitochondrial permeability transition pore.

Azzolin L, Antolini N, Calderan A, Ruzza P, Sciacovelli M, Marin O, Mammi S, Bernardi P, Rasola A.

PLoS One. 2011 Jan 28;6(1):e16280. doi: 10.1371/journal.pone.0016280.

8.

Cell-Penetrating Peptides: A Comparative Study on Lipid Affinity and Cargo Delivery Properties.

Ruzza P, Biondi B, Marchiani A, Antolini N, Calderan A.

Pharmaceuticals (Basel). 2010 Mar 30;3(4):1045-1062.

9.

Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies.

Rubini C, Ruzza P, Spaller MR, Siligardi G, Hussain R, Udugamasooriya DG, Bellanda M, Mammi S, Borgogno A, Calderan A, Cesaro L, Brunati AM, Donella-Deana A.

Biopolymers. 2010;94(3):298-306. doi: 10.1002/bip.21350.

PMID:
19921743
10.

Therapeutic prospect of Syk inhibitors.

Ruzza P, Biondi B, Calderan A.

Expert Opin Ther Pat. 2009 Oct;19(10):1361-76. doi: 10.1517/13543770903207039. Review.

PMID:
19670961
11.

Effect of 4-fluoro-L-proline on the SH3 binding affinity.

Ruzza P, Rubini C, Siligardi G, Hussain R, Calderan A, Guiotto A, Cesaro L, Brunati AM, Donella-Deana A.

Adv Exp Med Biol. 2009;611:499-500. No abstract available.

PMID:
19400283
12.

Introduction of N-alkyl residues in proline-rich peptides: effect on SH3 binding affinity and peptide conformation.

Ruzza P, Rubini C, Siligardi G, Hussain R, Calderan A, Guiotto A, Cesaro L, Brunati AM, Donella-Deana A.

Adv Exp Med Biol. 2009;611:65-6. No abstract available.

PMID:
19400095
13.

Mechanistic studies of amide bond scission during acidolytic deprotection of Pip containing peptide.

Rubini C, Osler A, Calderan A, Guiotto A, Ruzza P.

J Pept Sci. 2008 Aug;14(8):989-97. doi: 10.1002/psc.1032.

PMID:
18407579
14.

Malondialdehyde scavenging and aldose-derived Schiff bases' transglycation properties of synthetic histidyl-hydrazide carnosine analogs.

Guiotto A, Ruzza P, Babizhayev MA, Calderan A.

Bioorg Med Chem. 2007 Sep 15;15(18):6158-63. Epub 2007 Jun 20.

PMID:
17604632
15.

Neuroprotective actions of a histidine analogue in models of ischemic stroke.

Tang SC, Arumugam TV, Cutler RG, Jo DG, Magnus T, Chan SL, Mughal MR, Telljohann RS, Nassar M, Ouyang X, Calderan A, Ruzza P, Guiotto A, Mattson MP.

J Neurochem. 2007 May;101(3):729-36. Epub 2007 Jan 24.

16.

Spatial conformation and topography of the tyrosine aromatic ring in substrate recognition by protein tyrosine kinases.

Ruzza P, Cesaro L, Tourwé D, Calderan A, Biondi B, Maes V, Menegazzo I, Osler A, Rubini C, Guiotto A, Pinna LA, Borin G, Donella-Deana A.

J Med Chem. 2006 Mar 23;49(6):1916-24.

PMID:
16539378
17.

4-Fluoroproline derivative peptides: effect on PPII conformation and SH3 affinity.

Ruzza P, Siligardi G, Donella-Deana A, Calderan A, Hussain R, Rubini C, Cesaro L, Osler A, Guiotto A, Pinna LA, Borin G.

J Pept Sci. 2006 Jul;12(7):462-71.

PMID:
16506148
18.

Fluorescent, internally quenched, peptides for exploring the pH-dependent substrate specificity of cathepsin B.

Ruzza P, Quintieri L, Osler A, Calderan A, Biondi B, Floreani M, Guiotto A, Borin G.

J Pept Sci. 2006 Jul;12(7):455-61.

PMID:
16485313
19.

Carnosine and carnosine-related antioxidants: a review.

Guiotto A, Calderan A, Ruzza P, Borin G.

Curr Med Chem. 2005;12(20):2293-315. Review.

PMID:
16181134
20.

Synthesis and evaluation of neuroprotective alpha,beta-unsaturated aldehyde scavenger histidyl-containing analogues of carnosine.

Guiotto A, Calderan A, Ruzza P, Osler A, Rubini C, Jo DG, Mattson MP, Borin G.

J Med Chem. 2005 Sep 22;48(19):6156-61.

PMID:
16162015

Supplemental Content

Loading ...
Support Center